跳至主要内容
临床试验/NCT00937586
NCT00937586进行中(未招募)不适用

Prostate Cancer Prospective Cohort

Washington University School of Medicine1 个研究点 分布在 1 个国家目标入组 1,937 人开始时间: 2000年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
1,937
试验地点
1
主要终点
Ability to recognize increased risk of metastatic prostate cancer based on specific genetic polymorphisms.

研究概览

简要总结

The overall purpose of this research is to determine if certain genes increase the chance of developing prostate cancer and once diagnosed increase the chance of the prostate cancer spreading to other parts of the body.

详细描述

DNA will be isolated from each person and then studied for the presence of certain genes that may increase the chance of developing prostate cancer. Certain genes will also be studied in patients with known prostate cancer to determine if they increase the chance of cancer spreading to other parts of the body and decrease one's chance of being cured. Small differences in genes can slightly affect their ability to function. While these differences are normal, they may influence the way the cancer responds to therapy. An understanding of which genes increase (or decrease) the chance of being cured of a disease, such as prostate cancer, will improve our ability to take care of patients more effectively.

A second purpose of this study is to collect blood and cancer tissue for future studies. While the small differences in genes may be the best marker of bad cancer, it is also possible that proteins in blood or tumor may be a better marker.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Newly diagnosed patients:
  • newly diagnosis of prostate cancer
  • untreated except for neoadjuvant systemic therapy.

排除标准

  • Newly diagnosed patients:
  • inability to give informed consent

结局指标

主要结局

Ability to recognize increased risk of metastatic prostate cancer based on specific genetic polymorphisms.

时间窗: At the time of prostate cancer diagnosis

次要结局

  • Ability to predict risk for treatment failure based on analysis of specific polymorphisms.(At the time of prostate cancer diagnosis)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Prostate Cancer Prospective Cohort | 临床试验